NFE2L2 and cancer: On the other hand, oxidative stress in regulatory T cells strengthen their suppressor activity, and administration of an NRF2-inducing reagent sulforaphane inhibits tumor growth in allograft experiment (Maj et al. 2017), suggesting that NRF2 activation in cancer-bearing hosts is beneficial.